Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M I Morosini

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|June 22, 2014
[Treatment of Stenotrophomonas maltophilia meningoencephalitis with intraventricular colistin]V Romero Díaz-Maroto, C Pérez Menéndez-Conde, M I Morosini Reilly, et al.
Pediatric Pulmonology|October 23, 1997
Lung colonization with Enterobacteriaceae producing extended-spectrum beta-lactamases in cystic fibrosis patientsR Cantón, M I Morosini, S Ballestero, et al.
Protein Science : a Publication of the Protein Society|December 14, 1999
The complexed structure and antimicrobial activity of a non-beta-lactam inhibitor of AmpC beta-lactamaseR A Powers, J Blázquez, G S Weston, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 23, 2012
Assessment of the Phoenix™ automated system and EUCAST breakpoints for antimicrobial susceptibility testing against isolates expressing clinically relevant resistance mechanismsT Giani, M I Morosini, M M D'Andrea, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2001
In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanismsM I Morosini, R Cantón, E Loza, et al.
Journal of Clinical Microbiology|December 16, 2011
Clinical and microbiological features of a cystic fibrosis patient chronically colonized with Pandoraea sputorum identified by combining 16S rRNA sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometryA Fernández-Olmos, M I Morosini, A Lamas, et al.
Jac-Antimicrobial Resistance|February 23, 2023
Usefulness of EUCAST rapid antibiotic susceptibility breakpoints and screening cut-off values directly from blood cultures for the inference of β-lactam resistance mechanisms in EnterobacteralesV Cerrudo, J L Cortés-Cuevas, S García-Fernández, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 3, 2010
Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patientsM García-Castillo, R del Campo, F Baquero, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1995
New extended-spectrum TEM-type beta-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreakM I Morosini, R Canton, J Martinez-Beltran, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 25, 2007
IRT and CMT beta-lactamases and inhibitor resistanceR Cantón, M I Morosini, O Martín, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|June 22, 2014
[Treatment of Stenotrophomonas maltophilia meningoencephalitis with intraventricular colistin]V Romero Díaz-Maroto, C Pérez Menéndez-Conde, M I Morosini Reilly, et al.
Pediatric Pulmonology|October 23, 1997
Lung colonization with Enterobacteriaceae producing extended-spectrum beta-lactamases in cystic fibrosis patientsR Cantón, M I Morosini, S Ballestero, et al.
Protein Science : a Publication of the Protein Society|December 14, 1999
The complexed structure and antimicrobial activity of a non-beta-lactam inhibitor of AmpC beta-lactamaseR A Powers, J Blázquez, G S Weston, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 23, 2012
Assessment of the Phoenix™ automated system and EUCAST breakpoints for antimicrobial susceptibility testing against isolates expressing clinically relevant resistance mechanismsT Giani, M I Morosini, M M D'Andrea, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2001
In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanismsM I Morosini, R Cantón, E Loza, et al.
Journal of Clinical Microbiology|December 16, 2011
Clinical and microbiological features of a cystic fibrosis patient chronically colonized with Pandoraea sputorum identified by combining 16S rRNA sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometryA Fernández-Olmos, M I Morosini, A Lamas, et al.
Jac-Antimicrobial Resistance|February 23, 2023
Usefulness of EUCAST rapid antibiotic susceptibility breakpoints and screening cut-off values directly from blood cultures for the inference of β-lactam resistance mechanisms in EnterobacteralesV Cerrudo, J L Cortés-Cuevas, S García-Fernández, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 3, 2010
Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patientsM García-Castillo, R del Campo, F Baquero, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1995
New extended-spectrum TEM-type beta-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreakM I Morosini, R Canton, J Martinez-Beltran, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 25, 2007
IRT and CMT beta-lactamases and inhibitor resistanceR Cantón, M I Morosini, O Martín, et al.
Pageof 4